SILVER SPRING, MD – Boston Scientific is voluntarily recalling two core wires for its Rotablator Rotational Atherectomy System, according to an alert from the US Food and Drug Administration (FDA) [1] ...
PARIS, France—A novel atherectomy system designed to clear away hard plaque components may improve outcomes in patients with severely calcified coronary lesions compared with historical controls, ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Upfront high-speed rotational atherectomy may be more beneficial than angioplasty with modified ...
Please provide your email address to receive an email when new articles are posted on . In patients with severely calcified coronary lesions, planned rotational atherectomy appears to be a safe ...
November 11, 2011 (San Francisco, California) — Rotational atherectomy prior to the implantation of a drug-eluting stent (DES) failed to have any impact on in-stent late lumen loss in elderly patients ...
Becton, Dickinson and Company BDX, also popularly known as BD, recently received 510(k) clearance for expanded indications from the FDA for the Rotarex Atherectomy System. It is important to mention ...
The FDA today granted PMA approval to the Diamondback 360 Coronary Orbital Atherectomy System (OAS) for the treatment of severely calcified coronary arteries. Cardiovascular Systems, the manufacturer ...
Introduction of Orbital Atherectomy in Canada Expands Treatment Options for Patients with Complex Coronary Artery Disease Dr. Kalra said, “Patients with calcific coronary artery disease can have poor ...
An atherectomy is a minimally invasive procedure to remove plaque buildup from an artery (blood vessel). Removing this plaque allows blood to flow more freely through the artery. An atherectomy treats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results